Savara to Present at the Jefferies Global Healthcare Conference

Rhea-AI Summary

Savara, a clinical stage biopharmaceutical company focusing on rare respiratory diseases, announced its participation in the Jefferies Global Healthcare Conference. The management team will engage in a fireside chat scheduled for June 5, 2024, at 7:00am PT/10:00am ET. The event will be live-streamed on Savara's website and will remain accessible for 90 days. This conference is a significant platform for industry exposure, potentially impacting SVRA stock performance.

Positive

• Savara's participation in the Jefferies Global Healthcare Conference may increase investor interest and visibility.
• The event provides a platform for management to discuss strategic initiatives, potentially boosting investor confidence.
• Webcast availability for 90 days allows extended access for interested parties, increasing potential reach.

Negative

• The announcement lacks specific updates on financial performance or clinical trial progress, which might concern investors seeking concrete data.
• There is no mention of new partnerships, funding, or significant business developments, which could be seen as a missed opportunity to boost investor sentiment.

LANGHORNE, Pa.--(BUSINESS WIRE)-- Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that its management team will participate in a fireside chat at the Jefferies Global Healthcare Conference on June 5, 2024 at 7:00am PT/10:00am ET. A live webcast of the fireside chat will be available on Savara’s website at www.savarapharma.com/investors/events-presentations/ and will be archived for 90 days.

About Savara
Savara is a clinical stage biopharmaceutical company focused on rare respiratory diseases. Our lead program, molgramostim nebulizer solution, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). Molgramostim is delivered via an investigational eFlow^® Nebulizer System (PARI Pharma GmbH). Our management team has significant experience in rare respiratory diseases and pulmonary medicine, identifying unmet needs, and effectively advancing product candidates to approval and commercialization. More information can be found at www.savarapharma.com. (X, formerly known as Twitter: @SavaraPharma, LinkedIn: www.linkedin.com/company/savara-pharmaceuticals/).

View source version on businesswire.com: https://www.businesswire.com/news/home/20240529491002/en/

Savara Inc. IR & PR

Anne Erickson

anne.erickson@savarapharma.com

(512) 851-1366

Source: Savara Inc.

FAQ

When is Savara presenting at the Jefferies Global Healthcare Conference?

Savara will present at the Jefferies Global Healthcare Conference on June 5, 2024, at 7:00am PT/10:00am ET.

Where can I watch the Savara fireside chat at the Jefferies Global Healthcare Conference?

You can watch the live webcast of the Savara fireside chat on their website at www.savarapharma.com/investors/events-presentations/.

How long will the Savara fireside chat webcast be available?

The webcast will be archived and available on Savara’s website for 90 days.

What is the stock symbol for Savara?

The stock symbol for Savara is SVRA.